Table 2 Top 20 medications prescribed in public and private sector primary care practices
From: Variation of polypharmacy in older primary care attenders occurs at prescriber level
Medication Name | Proportions (%) | 95% CI |
|---|---|---|
Public Sector | ||
1. Amlodipine | 10.5 | (9.43–11.57) |
2. Metformin | 10.4 | (8.94–12.04) |
3. Lovastatin | 10.0 | (8.43–11.72) |
4. Perindopril | 7.9 | (6.77–9.17) |
5. Hydrochlorothiazide | 6.5 | (5.30–7.91) |
6. Gliclazide | 6.1 | (4.97–7.43) |
7. Acetylsalicylic Acid | 5.4 | (4.32–6.69) |
8. Metoprolol | 4.0 | (3.07–5.24) |
9. Simvastatin | 3.5 | (2.57–4.86) |
10. Atenolol | 2.6 | (1.88–3.52) |
11. Enalapril | 2.4 | (1.55–3.82) |
12. Insulin (Human) - Intermediate Acting | 2.0 | (1.61–2.48) |
13. Insulin (Human) - Intermediate- or Long-Acting Combine with Fast-Acting | 1.7 | (1.12–2.43) |
14. Prazosin | 1.6 | (1.10–2.43) |
15. Glibenclamide | 1.6 | (0.85–2.88) |
16. Gemfibrozil | 1.3 | (0.46–3.47) |
17. Furosemide | 1.2 | (0.80–1.70) |
18. Nifedipine | 1.1 | (0.59–1.97) |
19. Captopril | 1.0 | (0.55–1.74) |
20. Potassium Chloride | 1.0 | (0.56–1.67) |
Private Sector | ||
1. Diclofenac | 6.0 | (2.92–11.86) |
2. Paracetamol | 4.0 | (1.99–7.96) |
3. Prednisolone | 3.1 | (1.94–4.94) |
4. Theophylline | 2.6 | (1.00–6.52) |
5. Calcium, Combinations with Vitamin D and/or Other Drugs | 2.3 | (1.17–4.61) |
6. Bromhexine | 2.3 | (0.77–6.60) |
7. Atorvastatin | 2.2 | (0.85–5.57) |
8. Metformin | 2.2 | (1.13–4.09) |
9. Simvastatin | 2.1 | (0.81–5.37) |
10. Loratadine | 2.0 | (0.59–6.54) |
11. Amlodipine | 2.0 | (0.90–4.35) |
12. Dexamethasone | 1.6 | (0.35–6.92) |
13. Enzymes | 1.5 | (0.64–3.34) |
14. Clopidogrel | 1.4 | (0.57–3.64) |
15. Meloxicam | 1.4 | (0.74–2.73) |
16. Tonics | 1.4 | (0.24–7.42) |
17. Cefadroxil | 1.4 | (0.24–7.42) |
18. Insulin Glargine | 1.4 | (0.48–3.76) |
19. Atenolol | 1.4 | (0.62–2.93) |
20. Vitamin B1 in Combination with Vitamin B6 and/or Vitamin B12 | 1.2 | (0.51–3.03) |